共有 50 笔近期内部人交易记录记录，涉及 Ventyx Biosciences, Inc. (VTYX), 包括 24 笔买入 和 24 笔卖出. 内部人买入总额为 $7M 内部人卖出总额为 $2.56M.
近期活跃的重要内部人包括 Subramaniam Somu, Hulme Allison, Gujrathi Sheila. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — VTYX
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2025-06-05 |
Subramaniam Somu |
Director |
限制性股票授予 (RSU) |
40,000 |
$2.25 |
$90K |
40,000 |
| 2025-06-05 |
Hulme Allison |
Director |
限制性股票授予 (RSU) |
40,000 |
$2.25 |
$90K |
40,000 |
| 2025-06-05 |
Gujrathi Sheila |
Director |
限制性股票授予 (RSU) |
40,000 |
$2.25 |
$90K |
40,000 |
| 2025-06-05 |
White William Richard |
Director |
限制性股票授予 (RSU) |
40,000 |
$2.25 |
$90K |
40,000 |
| 2025-06-05 |
Cadoret-manier Onaiza |
Director |
限制性股票授予 (RSU) |
40,000 |
$2.25 |
$90K |
40,000 |
| 2025-05-15 |
Forman Mark S |
Chief Medical Officer |
限制性股票授予 (RSU) |
3,000 |
$1.03 |
$3.09K |
3,000 |
| 2025-05-15 |
Gonzales Roy |
Senior VP, Finance |
限制性股票授予 (RSU) |
1,750 |
$1.03 |
$1.8K |
3,546 |
| 2025-04-02 |
Nuss John |
Chief Scientific Officer |
知情卖出 |
1,887 |
$1.07 |
$2.02K |
467,226 |
| 2025-03-28 |
Subramaniam Somu |
Director |
其他（卖出） |
1,335,450 |
- |
- |
4,032,213 |
| 2025-03-28 |
Nuss John |
Chief Scientific Officer |
期权行权（卖出） |
4,531 |
- |
- |
9,063 |
| 2025-03-28 |
Mohan Raju |
CEO and President |
期权行权（卖出） |
11,844 |
- |
- |
23,688 |
| 2025-03-10 |
Subramaniam Somu |
Director |
其他（卖出） |
1,735,306 |
- |
- |
5,367,663 |
| 2025-01-02 |
Moore Matthew Richard |
Chief Operating Officer |
限制性股票授予 (RSU) |
145,000 |
$2.14 |
$310.3K |
145,000 |
| 2025-01-02 |
Nuss John |
Chief Scientific Officer |
限制性股票授予 (RSU) |
170,104 |
$2.14 |
$364.02K |
170,104 |
| 2025-01-02 |
Mohan Raju |
CEO and President |
限制性股票授予 (RSU) |
700,000 |
$2.14 |
$1.5M |
700,000 |
| 2025-01-02 |
Forman Mark S |
Chief Medical Officer |
限制性股票授予 (RSU) |
85,000 |
$2.14 |
$181.9K |
85,000 |
| 2025-01-02 |
Gonzales Roy |
Senior VP, Finance |
限制性股票授予 (RSU) |
17,500 |
$2.14 |
$37.45K |
17,500 |
| 2024-12-27 |
Nuss John |
Chief Scientific Officer |
知情卖出 |
21,119 |
$2.36 |
$49.84K |
464,582 |
| 2024-12-23 |
Gujrathi Sheila |
Director |
知情买入 |
130,000 |
$2.31 |
$300.57K |
130,000 |
| 2024-12-19 |
Nuss John |
Chief Scientific Officer |
知情卖出 |
13,161 |
$2.26 |
$29.68K |
485,701 |
| 2024-12-17 |
Nuss John |
Chief Scientific Officer |
期权行权（卖出） |
34,930 |
- |
- |
34,930 |
| 2024-12-17 |
Mohan Raju |
CEO and President |
期权行权（卖出） |
116,668 |
- |
- |
116,668 |
| 2024-12-10 |
Nuss John |
Chief Scientific Officer |
期权行权（卖出） |
193,557 |
$0.20 |
$38.71K |
- |
| 2024-11-25 |
Mohan Raju |
CEO and President |
知情买入 |
261,752 |
$2.01 |
$524.94K |
2,175,028 |
| 2024-11-22 |
Mohan Raju |
CEO and President |
知情买入 |
238,248 |
$1.83 |
$434.95K |
1,913,276 |
| 2024-08-30 |
Gonzales Roy |
Senior VP, Finance |
处置 |
70,000 |
$33.84 |
$2.37M |
- |
| 2024-08-12 |
Forman Mark S |
Officer |
未知 |
- |
- |
- |
- |
| 2024-08-12 |
Forman Mark S |
Chief Medical Officer |
限制性股票授予 (RSU) |
350,000 |
$1.95 |
$682.5K |
350,000 |
| 2024-06-24 |
Subramaniam Somu |
10 Percent Owner |
其他（卖出） |
641,327 |
- |
- |
7,102,969 |
| 2024-06-24 |
Nsv Partners Iii Lp |
10 Percent Owner |
其他（卖出） |
641,327 |
- |
- |
7,102,969 |
| 2024-06-10 |
Mohan Raju |
CEO and President |
期权行权（卖出） |
96,778 |
$0.20 |
$19.36K |
- |
| 2024-06-06 |
Subramaniam Somu |
10 Percent Owner |
限制性股票授予 (RSU) |
33,000 |
$3.29 |
$108.41K |
33,000 |
| 2024-06-06 |
Hulme Allison |
Director |
限制性股票授予 (RSU) |
33,000 |
$3.29 |
$108.41K |
33,000 |
| 2024-06-06 |
Gujrathi Sheila |
Director |
限制性股票授予 (RSU) |
33,000 |
$3.29 |
$108.41K |
33,000 |
| 2024-06-06 |
White William Richard |
Director |
限制性股票授予 (RSU) |
33,000 |
$3.29 |
$108.41K |
33,000 |
| 2024-06-06 |
Cadoret-manier Onaiza |
Director |
限制性股票授予 (RSU) |
33,000 |
$3.29 |
$108.41K |
33,000 |
| 2024-05-16 |
Moore Matthew Richard |
Officer |
未知 |
- |
- |
- |
- |
| 2024-05-16 |
Moore Matthew Richard |
Chief Operating Officer |
限制性股票授予 (RSU) |
320,000 |
$4.98 |
$1.59M |
320,000 |
| 2024-04-12 |
Subramaniam Somu |
10 Percent Owner |
其他（卖出） |
695,339 |
- |
- |
7,744,296 |
| 2024-04-12 |
Nsv Partners Iii Lp |
10 Percent Owner |
其他（卖出） |
695,339 |
- |
- |
7,744,296 |
| 2024-04-02 |
Krueger Christopher W |
Chief Business Officer |
知情卖出 |
1,651 |
$5.40 |
$8.92K |
284,999 |
| 2024-04-02 |
Nuss John |
Chief Scientific Officer |
知情卖出 |
1,651 |
$5.40 |
$8.92K |
264,998 |
| 2024-04-02 |
Auster Martin |
Chief Financial Officer |
知情卖出 |
1,405 |
$5.40 |
$7.59K |
24,303 |
| 2024-04-02 |
Mohan Raju |
CEO and President |
知情卖出 |
4,312 |
$5.40 |
$23.3K |
1,578,250 |
| 2024-03-28 |
Krueger Christopher W |
Chief Business Officer |
期权行权（卖出） |
4,531 |
- |
- |
13,594 |
| 2024-03-28 |
Nuss John |
Chief Scientific Officer |
期权行权（卖出） |
4,531 |
- |
- |
13,594 |
| 2024-03-28 |
Auster Martin |
Chief Financial Officer |
期权行权（卖出） |
4,531 |
- |
- |
13,594 |
| 2024-03-28 |
Mohan Raju |
CEO and President |
期权行权（卖出） |
11,843 |
- |
- |
35,532 |
| 2024-01-21 |
Subramaniam Somu |
10 Percent Owner |
限制性股票授予 (RSU) |
20,000 |
$1.97 |
$39.4K |
20,000 |
| 2024-01-21 |
Hulme Allison |
Director |
限制性股票授予 (RSU) |
20,000 |
$1.97 |
$39.4K |
20,000 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
